Integrating molecular subtype and CD8⁺ T cells infiltration to predict treatment response and survival in muscle-invasive bladder cancer.

"Declarations Conflicts of interestThe authors have declared no conflicts of interest. Ethics approvalThis study was approved by the Clinical Research Ethics Committee of Zhongshan Hospital and Fudan University (No. B2015-030). Informed consentWritten informed consent was obtained from each patient. Conflicts of interest The authors have declared no conflicts of interest."

"Funding This study was funded by grants from National Natural Science Foundation of China (82002670, 82103408, 82272930, 82372793, 82373276), China Postdoctoral Science Foundation (BX20230091), Shanghai Municipal Natural Science Foundation (22ZR1413400, 23ZR1411700, 23ZR1440300), Shanghai Sailing Program (21YF1407000), Fudan University Shanghai Cancer Center for Outstanding Youth Scholars Foundation (YJYQ201802) and Shanghai Anticancer Association EYAS PROJECT (SACA-CY22B02, ZYJH202309). All these study sponsors have no roles in the study design, in the collection, analysis and interpretation of data."